Khaberni - Today, the Israeli company (Precise Bio) announced an unprecedented medical achievement on a global level, after it succeeded in printing a three-dimensional human cornea entirely produced in the lab and implanting it for the first time in a human eye, instead of relying on corneas from donors.
The surgical operation was conducted on October 29 at Rambam Hospital in Haifa, by Professor Khaberni Michael Mimon, for a patient suffering from severe vision impairment and considered legally blind. According to the hospital's announcement, the patient's vision significantly improved after the surgery, and he is currently undergoing a critical observation period that will determine the stability of the implanted cornea's performance.
The printed cornea, developed to be similar to the natural cornea in terms of transparency, strength, and structure, forms itself during the implantation process. Currently, Khaberni is testing it in the first phase of a clinical trial in Israel, which is expected to involve 10 to 15 patients suffering from endothelial cell diseases of the cornea, leading to fluid accumulation affecting vision.
The company expects to publish preliminary test results in the second half of 2026. It hopes that this technology will represent a medical breakthrough that can contribute to solving the acute global shortage of corneas available for transplantation, and open a new door for treating blindness-related corneal diseases worldwide.
.
